Search
Displaying results 381 to 390 of 670.
Project "ChloroMalaria": New class of active ingredients against tropical disease
The infectious disease malaria causes more than 600,000 deaths annually and threatens about half of the global population. As the malaria pathogen Plasmodium falciparum is increasingly developing resistance to the drugs used to treat it, research into new active agents…
Interrogating disease progression and cell processes with TIGER: in vivo and non-invasively
Bacterial and viral infections can cause severe acute symptoms, but they can also have devastating long-term consequences such as triggering cancer. Consequently, scientists are looking for new approaches and technologies to better understand the course of diseases and…
Researchers from Würzburg and the U.S. discover new type of CRISPR gene scissors
Like humans, bacteria and archaea can be attacked by viruses. These microorganisms have developed their own immune defense strategies against their pathogens. Bacterial defenses, such as CRISPR-Cas systems, have diverse proteins and functions that help bacteria protect…
Progress toward Improved Vaccines
α-GalCer is a synthetic glycolipid (a compound made from fat and sugar building blocks) based on similar compounds found in sea sponges. It binds to CD1-d, a special receptor on antigen-presenting cells. This activates certain immune cells and induces secretion of…
Project “Microbelix” takes a close look at the soil habitat
In order to find new active ingredients for the treatment of infectious diseases, HIPS researchers are taking a close look at soil bacteria that are known to produce natural products with promising pharmaceutical properties. These are then tested in the laboratory for…
Geneticist Josef Penninger becomes new Scientific Director of the Helmholtz Centre for Infection Research
Prof Veronika von Messling, Ministerial Director of the Federal Ministry of Education and Research (BMBF) and Chairwoman of the Supervisory Board of the HZI, explained that “We are very pleased to have Prof Josef Penninger, an outstanding researcher, as the new…
New building for innovation in infection research
Emerging pathogens, increasing antibiotic resistance and chronic infections are among the greatest health challenges of our time. With the aim of developing new strategies and therapies against known and novel infectious diseases, the Würzburg Helmholtz Institute for…
Stephan Weil: “Thank you for your tireless commitment”
“We are now about two years after the start of the Corona pandemic and I would like to take this opportunity to express my sincere thanks to the entire staff of the HZI as representatives of science and research in Lower Saxony,” said Minister President Stephan Weil at…
1.5 million euros for research on SARS-CoV-2
The grants of the European Research Council (ERC) are among the most important and prestigious funding instruments in science. Accordingly, there is great joy about receiving the award – not only in Würzburg, but also in Braunschweig: HIRI is a location of the Helmholtz…
Ceremonial handover of office at the HZI
Josef Penninger, a geneticist who has received numerous international awards, previously headed the Life Sciences Institute at the University of British Columbia (Canada). At the same time as taking over the scientific management of the HZI, Penninger was also appointed…
